undamentalytics Newsletter
Sign in

Tonix Pharmaceuticals Holding Corp. balance sheet

At the end of fiscal 2025, Tonix Pharmaceuticals Holding Corp. had total assets of $277m, total liabilities of $32.0m and shareholders' equity of $245m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents2599208176
Receivables—4612
Inventory148——
Total current assets48119229203
Goodwill1———
Total assets154163277254
Accounts payable4589
Deferred revenue (current)3234
Total current liabilities19183131
Short-term debt23——
Long-term debt75——
Total debt119—0
Total liabilities49233232
Shareholders' equity106140245222
Shares outstanding———17m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ARCT vs TNXPGLUE vs TNXPSTOK vs TNXP

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Tonix Pharmaceuticals Holding Corp.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Tonix Pharmaceuticals Holding Corp.